About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Study Finds Less Than One Percent of Research Funding by Charity Organizations Spent on Antibiotic Research

by Kathy Jones on July 25, 2014 at 8:47 PM
Font : A-A+

 Study Finds Less Than One Percent of Research Funding by Charity Organizations Spent on Antibiotic Research

A new study published in the journal The Lancet Infectious Diseases reveals that less than one percent of the funding awarded by public and charitable bodies to British researchers in 2008 was for research on new antibiotics.

The study, which is the first detailed assessment of public and charitable funding to UK researchers focusing on bacteriology and antibiotic research, suggests that present levels of funding for antibiotic research in the UK are inadequate, and will need to be urgently increased if the growing crisis of antibiotic resistance is to be tackled effectively by UK researchers.

Advertisement

According to lead author Professor Laura Piddock, of the University of Birmingham, UK, "The message that antibacterial (ie, antibiotic) drug resistance has become a world health crisis has been brought to global attention by WHO, the European Union (EU), the World Economic Forum, and, most recently, the UK Chief Medical Officer. As a world leader in biomedical research, UK research has an important part to play in tackling this crisis. However, our study clearly shows that the proportion of public and charitable funding for research into new antibiotics, understanding resistance mechanisms and ways of tackling resistance are inadequate for the size of the task." Professor Piddock and her colleague analysed funding databases for the UK's main research funding organisations, finding that of 138 billion total available research funding, 269 million (19%) was awarded to bacteriology projects, and around a third of this (95 million or 07% of total funding) was awarded for research on antibiotics.

Additionally, 181 million in EU funding was awarded to antibiotic research consortia including researchers based within the UK, including two EU Innovative Medicines Initiative awards, totalling 85 million. While this article focused exclusively on research funding for antibiotics, previous studies have shown that funding for other antimicrobials (antifungals and antivirals) is similarly low as a proportion of total funding. As well as demonstrating that the proportion of research funding given for UK antibiotic research will need to increase, the authors suggest that publically available, subject-specific, funding databases will allow investment in priority areas to be tracked in future. "Since 2011, most new EU funding has focused on public-private partnerships with industry", adds Professor Piddock. "However, an increased understanding about antibiotic resistance is needed, not least to inform strategies to both minimise and prevent antibiotic-resistant bacteria arising when new treatments become available." In a linked Comment, Dr Michael G Head from the Farr Institute, University College London, UK, said "The private sector needs to be more transparent about how much they invest in areas related to antibiotics (generation of new therapeutics being an obvious and particularly important area), so that their data can be similarly analysed in detail. Efforts to document the investments of other countries regarding antibiotic resistance research would be beneficial and would allow funders and policymakers to chart the optimum future direction of research money. Metrics to establish the true burden of antibiotic resistance and methods also to assess the likely effect of other types of research are needed; for example, preventive research such as vaccine development will affect future burdens of bacterial infections and resistance."



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Softening Stem Cells Enhances Hair Growth Potential
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
Potential New Strategy for Ischemic Stroke Discovered
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
Is Speech Therapy the Answer to Voice Problems in Parkinson's Disease Patients
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.
 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Study Finds Less Than One Percent of Research Funding by Charity Organizations Spent on Antibiotic Research Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests